Acadian Asset Management LLC raised its holdings in shares of Ultralife Co. (NASDAQ:ULBI – Free Report) by 4.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,635 shares of the technology company’s stock after purchasing an additional 6,206 shares during the quarter. Acadian Asset Management LLC owned approximately 0.88% of Ultralife worth $1,556,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in ULBI. Victory Capital Management Inc. acquired a new stake in shares of Ultralife during the fourth quarter worth $59,000. O Shaughnessy Asset Management LLC acquired a new stake in shares of Ultralife during the first quarter worth $100,000. Rhumbline Advisers lifted its holdings in shares of Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after buying an additional 11,165 shares in the last quarter. Perritt Capital Management Inc. lifted its holdings in shares of Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock worth $132,000 after buying an additional 3,000 shares in the last quarter. Finally, D.A. Davidson & CO. acquired a new stake in shares of Ultralife during the fourth quarter worth $163,000. Institutional investors and hedge funds own 30.68% of the company’s stock.
Ultralife Stock Up 2.0 %
Shares of NASDAQ ULBI opened at $9.55 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. Ultralife Co. has a 52 week low of $6.36 and a 52 week high of $13.39. The stock has a market capitalization of $158.72 million, a P/E ratio of 14.92 and a beta of 0.98. The stock’s fifty day moving average is $10.54 and its 200 day moving average is $10.37.
Analysts Set New Price Targets
ULBI has been the subject of a number of research reports. Benchmark lifted their target price on Ultralife from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, June 27th. StockNews.com upgraded Ultralife from a “buy” rating to a “strong-buy” rating in a research report on Monday, August 12th.
Get Our Latest Stock Analysis on ULBI
Ultralife Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
- Five stocks we like better than Ultralife
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Buy Cheap Stocks Step by Step
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- 3 Best Fintech Stocks for a Portfolio Boost
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.